₹102.18
Above FV▼ -49.4% against the close used
Model range ₹62.26 – ₹143.45
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Bear₹62.26Fair value₹102.18Bull₹143.45
FairClose
52-week traded range
52W low ₹95.0352W high ₹205.89
The 52-week range is measured from the stored price history, not estimated.
Trading above the consensus fair value
Amanta Healthcare Limited closed at ₹201.78, 97.5% above the consensus fair value of ₹102.18 drawn from 7 valuation models.
Financial DNA score 19/100 — Weak. P/E of 50.1x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
DCF Valuation
₹71.78
-64.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹71.73
-64.5%
√(22.5 × EPS × BVPS)
EPS=3.83, BVPS=59.7 · outside Graham range (P/E 50.1, P/B 3.4) — asset-light, treat as a rough floor
P/E Fair Value
₹136.73
-32.2%
EPS × 35.7x (sector P/E)
EPS=3.83, Sector P/E=35.7x
EV/EBITDA
₹143.45
-28.9%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=790M
Book Value (P/B)
₹62.26
-69.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=59.7, ROE=10.3%, g=3%, r=10%
Reverse DCF
₹201.78
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 20.2% | Historical: 0%
Margin of Safety
₹70.06
-65.3%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=93.41, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.